Vonoprazan fumarate for the management of acid-related diseases
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1346087
Abstract: ABSTRACT Introduction: Proton pump inhibitors (PPIs) display a number of limitations and unmet clinical needs that have prompted the development of novel drugs to improve the outcomes of acid-related diseases, including the eradication of H.… read more here.
Keywords: vonoprazan fumarate; fumarate management; related diseases; acid related ... See more keywords
Spectrophotometric quantitative analysis of aspirin and vonoprazan fumarate in recently approved fixed-dose combination tablets using ratio spectra manipulating tools.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of AOAC International"
DOI: 10.1093/jaoacint/qsac128
Abstract: BACKGROUND Low-dose aspirin is prescribed to millions of people around the world as a secondary preventative strategy for the majority of significant cardiovascular events, however it carries a substantial risk of gastric ulcer and bleeding.… read more here.
Keywords: ratio spectra; aspirin vonoprazan; aspirin; vonoprazan fumarate ... See more keywords
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Experimental Gastroenterology"
DOI: 10.2147/ceg.s228352
Abstract: Abstract Potassium-competitive acid blockers (P-CABs), such as vonoprazan, represent a novel and heterogeneous class of drugs that competitively block the potassium binding site of gastric H+/K+ ATPase, thus potentially overcoming the limitations of proton-pump inhibitors.… read more here.
Keywords: review; treatment gastric; treatment; vonoprazan ... See more keywords